Solventum, an American healthcare company spun off from 3M in 2024, has completed the sale of its purification and filtration business to Thermo Fisher Scientific for approximately USD 4 billion in cash, subject to customary adjustments, effective 1 September 2025.
The divested business is a leading global provider of purification and filtration technologies used in the production of biologics, as well as in medical technologies and industrial applications. It operates worldwide, with sites across the Americas, Europe, the Middle East, Africa, and the Asia-Pacific region.
Paksoy is pleased to announce that a team led by partner Stéphanie Beghe Sönmez and associates Meriç Saçak Albaş and Cansın Taner acted as Turkish counsel to Solventum, alongside Cleary Gottlieb Steen & Hamilton, which served as global counsel on this multijurisdictional transaction.
Share
Related persons
You can contact us for detailed information.


Legal Information
This briefing is for information purposes; it is not legal advice. If you have questions, please call us. All rights reserved.
You May Be Interested In
19 January 2026
Paksoy advises Amphenol on its acquisition of CommScope’s CCS business
Paksoy advises Amphenol Corporation on its acquisition of CommScope’s Connectivity and Cable Solutions (CCS) business.
14 January 2026
Paksoy advised Stellantis Group on the sale of BPF Pazarlama to TOFAŞ
Paksoy advised Stellantis Group on the sale of BPF Pazarlama to TOFAŞ.
13 January 2026
Paksoy advised IFC on its investment in Getmobil
Paksoy advised IFC on its investment in Getmobil.
12 January 2026
Mergermarket has ranked us #1 Legal Adviser in Turkey by deal value for 2025
Mergermarket has ranked us #1 Legal Adviser in Turkey by deal value for 2025, advising on USD 4.97 billion across 18 transactions.
7 January 2026
Paksoy advises Sanofi on the sale of a majority stake in its Lüleburgaz manufacturing facility
Paksoy advises Sanofi on the sale of a majority stake in its Lüleburgaz manufacturing facility.
5 January 2026
We are pleased to announce the promotion of Sabri Kaya to Counsel, effective as of 1 January 2026
We extend our congratulations to Sabri Kaya on his well-deserved promotion to Counsel.
